Company
MBX Biosciences, Inc. (MBX)
Standardized SEC financial data for MBX Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001776111 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-23.6%
Free cash flow
-$81.9M
Current ratio
24.62×
EPS (diluted)
$-2.38
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| R&D expense | $28.5M | $57.4M | $79.2M |
| SG&A expense | $6.8M | $10.8M | $18.9M |
| Operating income | -$35.3M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | — | $30.5M | $262.1M | $373.7M |
| Total current assets | — | $83.5M | $267.3M | $381.5M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$32.0M | -$54.7M | -$79.9M |
| Capital expenditures | $129K | $874K | $1.9M |
| Free cash flow | -$32.1M | -$55.6M |
Get MBX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MBX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MBX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"